NEW YORK, Jan. 16 /PRNewswire/ -- Investment and M&A activity in the life sciences and healthcare sector is at an all-time high and expected to grow even more in 2008. CEOs, CFO's and other business executives from pharmaceutical, biotech, medical and other life sciences companies will be joined by some of the most sophisticated investors in the industry at the 2008 Investment and M&A Opportunities in Healthcare, April 30-May 1, 2008, in Chicago.
Deal volume in the healthcare sector in October 2007 surged to its
highest month level ever. A total of 102 deals -- with over $14.0 billion
in commitments -- is evidence that investment and M&A activity in the
healthcare space will be robust in 2008 and beyond:
Medical Devices: 20 Deals in October 2007
Biotechnology: 19 Deals in October 2007
Pharmaceuticals: 19 Deals in October 2007
In 2005, there were 33 such deals amounting to $16.5 billion, while in
the first 9 months of 2007, 49 deals totaling $28.7 billion were
consummated. Financial buyers, led by private equity, hedge funds and other
investors are also continuing to play a big role in this space.
Preliminary speaking faculty includes:
-- Donald Adam, Senior VP & Chief Development Officer, RehabCare Group
-- Christine Arakelian, VP, Business Development, Omnicare
-- Bill Baker, Partner, KPMG LLP, Transaction Services
-- Andy Bressler, Managing Director, Banc of America Securities
-- Jay Dennis, VP, Technology, IBM Corporation
-- Steven Elek, III, Leader, Healthcare Transaction Services,
-- David Ertel, Managing Director, Morgan Stanley
-- Bob Funari, CEO, Crescent Healthcare
-- Matthew Gallivan, President, Nashville Health Care Council
-- Scott Kozicki, Founder & CEO, Truu Health, Inc.
-- Philip A. Borden, Principal, Riverside Partners
-- Geoffrey Ligibel, CFA, VP, Healthcare Grou
Copyright©2008 PR Newswire.
All rights reserved